Background Amyotrophic lateral sclerosis (ALS) is a progressive and usually fatal neurodegenerative disease. Survival from diagnosis varies considerably. Several prognostic factors are known, ...

Background The diagnostic value of new criteria of the European Academy of Neurology/Peripheral Nerve Society (EAN/PNS) for chronic inflammatory demyelinating polyneuropathy (CIDP) is unknown. Methods ...

1 Rush Institute for Healthy Aging, Centers for Disease Control and Prevention, Atlanta, GA, USA 2 Department of Internal Medicine, Centers for Disease Control and Prevention, Atlanta, GA, USA 3 ...

Objectives Neurochemical markers of amyotrophic lateral sclerosis (ALS) that reflect underlying disease mechanisms might help in diagnosis, staging and prediction of outcome. We aimed at determining ...

Parkinson’s disease (PD) is associated with an increased risk of melanoma, but the link between levodopa therapy and melanoma is less clear. The Electronic Medicines Compendium (EMC) explicitly ...

Correspondence to Professor J Jankovic, Parkinson’s Disease Center, and Movement Disorders Clinic, Baylor College of Medicine, Department of Neurology, The Smith Tower, Suite 1801, 6550 Fannin, ...

1 Division of Neurology, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Prince of Wales Hospital, Shatin, Hong Kong 2 Department of Clinical and Experimental Epilepsy, ...

Background Cerebellar ataxias are the result of diverse disease processes that can be genetic or acquired. Establishing a diagnosis requires a methodical approach with expert clinical evaluation and ...

2 Department of Forensic Pathology, Auckland Hospital, Auckland, New Zealand 3 Faculty of Medicine and Health Sciences, University of Auckland, Auckland, New Zealand Correspondence to Professor A ...

Objective: Parkinson’s disease (PD) is a progressive neurological disorder characterised by a large number of motor and non-motor features that can impact on function to a variable degree. This review ...

1 Alzheimer Centre and VU University Medical Centre, Amsterdam, The Netherlands 2 Department of Neurology, VU University Medical Centre, Amsterdam, The Netherlands 3 Department of Neurology and MRI ...

Original research: Swedish nationwide study of 377 patents with non-aneurysmal subarachnoid haemorrhage: a disease with distinct demographics and risk factors (20 November, 2025) ...